Formulations of pimavanserin | Patent Publication Number 20220193057

US 20220193057 A1
Patent NumberUS 11452721 B2
Application Number17693830
Filled DateMar 14, 2022
Priority DateAug 30, 2017
Publication DateJun 23, 2022
Original AssigneeAcadia Pharmaceuticals Inc.
Current AssigneeAcadia Pharmaceuticals Inc.
Inventor/ApplicantsRavindra Tejwani
Stephen Edward Abele
Emanuel Joseph Vizzotti
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.